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Mediator protein complex subunit 12 (Med12) is a core component of the basal transcriptional apparatus and plays a critical
role in the development of many tissues. Mutations in Med12 are associated with X-linked intellectual disability syndromes
and hearing loss; however, its role in nervous system function remains undefined. Here, we show that temporal conditional
deletion of Med12 in astrocytes in the adult CNS results in region-specific alterations in astrocyte morphology. Surprisingly,
behavioral studies revealed rapid hearing loss after adult deletion of Med12 that was confirmed by a complete abrogation of
auditory brainstem responses. Cellular analysis of the cochlea revealed degeneration of the stria vascularis, in conjunction
with disorganization of basal cells adjacent to the spiral ligament and downregulation of key cell adhesion proteins.
Physiologic analysis revealed early changes in endocochlear potential, consistent with strial-specific defects. Together, our
studies reveal that Med12 regulates auditory function in the adult by preserving the structural integrity of the stria
vascularis.
Key words: astrocyte; hearing loss; mediator complex; stria vascularis
Significance Statement
Mutations in Mediator protein complex subunit 12 (Med12) are associated with X-linked intellectual disability syndromes
and hearing loss. Using temporal-conditional genetic approaches in CNS glia, we found that loss of Med12 results in severe
hearing loss in adult animals through rapid degeneration of the stria vascularis. Our study describes the first animal model
that recapitulates hearing loss identified in Med12-related disorders and provides a new system in which to examine the
underlying cellular and molecular mechanisms of Med12 function in the adult nervous system.

Introduction
Glial cell support of neuronal function is a hallmark feature of
nervous systems across evolution, with both glial abundance and
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specialization correlated with increasing neuronal and organism
complexity (Freeman and Rowitch, 2013). Accordingly, mammalian systems contain a host of specialized glial cells that subserve neuronal function, with astrocytes serving as an archetype
for glial support (Allen and Lyons, 2018; Nagai et al., 2021).
Among the key functions performed by astrocytes include buffering neurotransmitters, maintenance of ion gradients, and providing metabolic support, all of which directly influence the
function of neurons and associated circuits (Khakh and Deneen,
2019).
In the mammalian auditory system hair cells use mechanosensation to convert energy from soundwaves into neurophysiological signals that are transmitted to the brainstem (Brownell et
al., 1985; Chan and Hudspeth, 2005; Muller, 2008). Hair cell
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function relies on the endocochlear potential (EP), which is an
ion gradient established in the endolymph and maintained by
the stria vascularis (Gulley and Reese, 1976; Patuzzi, 2011). The
resting potential of the endolymph is regulated by the transport
of K1 ions across the stria vascularis into the cochlear duct
(Gründer et al., 2001; Boettger et al., 2002; Mittal et al., 2017).
This function is mediated by potassium channels, including
Kir4.1, which is the predominant channel used by astrocytes to
buffer neuronal K1 (Rozengurt et al., 2003; Chen and Zhao,
2014). Critically, disruption of these electrochemical gradients in
the endolymph can lead to altered hair cell function and survival,
culminating in a loss of hearing (Nin et al., 2016; Mittal et al.,
2017). While much progress has been made in understanding
how the stria vascularis regulates endocochlear potential, the
transcriptional mechanisms that control stria vascularis function
remain poorly defined.
Glial development offers a venue in which to identify transcription factors that regulate mature glial cell function. For
example, Sox10 and NFIA (nuclear factor IA) are key regulators
of oligodendrocyte and astrocyte development, respectively, and
the physiological functions of these cells in the adult CNS (Stolt
et al., 2002; Huang et al., 2020). These parallels also apply to auditory support cells, where Sox2, Sox9, and Sox10 are expressed
in developing and mature CNS glia and support cells in the cochlea (Watanabe et al., 2000; Oesterle et al., 2008; Loponen et al.,
2011). Drawing on this parallel, we identified Mediator Complex
Subunit 12 (Med12) as a developmental transcription factor that
is enriched in subsets of astrocytes in the adult brain (John Lin et
al., 2017). Studies in development have shown that Med12 cooperates with Sox10 to regulate oligodendrocyte differentiation
(Vogl et al., 2013); however, its role in mature astrocytes is undefined. Furthermore, mutations in Med12 are linked to intellectual disability syndromes and are coupled with hearing loss
(Schwartz et al., 2007; Lesca et al., 2013; Vulto-van Silfhout et al.,
2013; Donnio et al., 2017; Rubinato et al., 2020). These observations implicate Med12 as a critical transcription factor contributing to a host of nervous systems functions related to neuronal
circuits, myelination, and auditory function. Despite its widespread expression in neurons and glia, the precise role of Med12
in the adult CNS remains unknown.
To dissect the contributions of Med12 toward brain function,
we generated temporal–conditional mouse knock-out (KO)
models that enabled us to delete Med12 in astrocytes. Analysis
across brain regions revealed reduced astrocyte complexity in the
hippocampus, while behavioral studies revealed that mice lacking
astrocytic-Med12 are deaf and have no auditory brainstem
response (ABR). Cellular analysis of the cochlea revealed that
Med12 is required to maintain the integrity of the stria vascularis, which eventually results in eventual loss of hair cells.
Together, these studies identify Med12 in the stria vascularis as a
key regulator of auditory function.

Materials and Methods

Animals
All experimental animals were treated in compliance with the US
Department of Health and Human Services, the National Institutes of
Health guidelines, and Baylor College of Medicine Institutional Animal
Care and Use Committee (IACUC) guidelines. All mice were housed
with food and water available ad libitum in a 12 h light/dark environment. Both female and male mice were used for all experiments, and littermates of the same sex were randomly allocated to experimental
groups. For histologic analyses of brains and behavior assays, 4-monthold adult mice were used unless otherwise described. For ABR test and
histologic analyses of inner ears, examinations or tissue collections were
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performed at 1, 2, 3, or 5 weeks after the tamoxifen (TM) treatment, as
described. All mice used in this study were maintained on a C57BL/6J
background. Med12 conditional knock-out mice were generated by
crossing Med12fl/fl or Med12fl/y conditional mutant mice (Rocha et al.,
2010a,b) with Aldh1l1-CreER (The Jackson Laboratory; RRID:IMSR_
JAX:029655), resulting in Med12fl/fl; Aldh1l1-CreER or Med12fl/y;
Aldh1l1-CreER (A12-KO) and Med12fl/fl or Med12fl/y (A12-Con) littermate controls. For histologic analysis, the Aldh1l1-GFP mouse was
crossed with the A12-KO mouse, resulting in Med12fl/fl (or Med12fl/y);
Aldh1l1-CreER; Aldh1l1-GFP (AG12-KO) and Med12fl/fl (or Med12fl/y);
Aldh1l1-GFP (AG12-Con) mice. To mark the Cre-targeted cells, RosaCAG-LSL-tdTomato-WPRE mice were crossed with A12-KO mice,
resulting in Med12fl/fl (or Med12fl/y); Aldh1l1-CreER; Rosa-CAG-LSLtdTomato-WPRE (AT12-KO) and Med121/1 (or Med121/y); and
Aldh1l1-CreER; Rosa-CAG-LSL-tdTomato-WPRE (AT12-Con) mice.
To induce deletion of Med12 in the adult, 4-week-old mice were gavage
fed with 150 mg/kg body weight tamoxifen (catalog #T5648, SigmaAldrich) dissolved in corn oil twice per day for 5 d. The above experiments were approved by Baylor College of Medicine IACUC.
Immunofluorescence on frozen tissue sections
Mice were anesthetized under isoflurane inhalation and perfused transcardially with 1 PBS, pH 7.4, followed by 4% paraformaldehyde (PFA).
Brains were removed, postfixed in 4% PFA for 8 h, and placed in 20%
sucrose for 16 h before being embedded in optimal cutting temperature
(OCT) compound. Inner ears were dissected from temporal bones and
fixed in 4% PFA overnight, decalcified in 0.2 M EDTA for 24 h.
Decalcified inner ears were incubated in 7.5% gelatin solution (1 PB/
10% sucrose) at 37°C for 1 h before being embedded in OCT compound.
Brain sections of 30 mm and cochlea sections of 12 mm were made on a
cryostat. For immunostaining, tissue sections were washed with 1 PBS
for 5 min three times, blocked with 10% goat serum in PBS with 0.3%
Tween 20, and then incubated with primary antibodies in blocking solution overnight. On the next day, sections were incubated with secondary
antibodies in PBS with 0.1% Tween 20 for 1 h at room temperature, followed by incubation with DAPI for 5 min, and mounted with
VECTASHIELD Antifade Mounting Media (catalog #H-1000, Vector
Laboratories). The following primary antibodies were used: chicken
anti-GFP (1:1000; catalog #ab13970, abcam); rabbit anti-Med12 (1:1000;
catalog #NB100-2357, Novus Biologicals); chicken anti-GFAP (1:1000;
catalog #ab4674, abcam); mouse anti-GFAP (1:1000; catalog #MAB360,
EMD Millipore); mouse anti-NeuN (1:500; catalog #MAB377, Millipore);
rabbit anti-myosin-VIIa (1:1000; catalog #25–6790, Proteus BioSciences);
mouse anti-myosin-VIIa (1:500; catalog #MYO7A, Development Studies
Hybridoma Bank); rabbit anti-Sox2 (1:1000; catalog #AB5603, Millipore);
rat anti-Sox2 (1:1000; catalog #14–9811-82, Thermo Fisher Scientific); rabbit anti-GLUT1 (1:500; catalog #ab115730, abcam); mouse anti-ZO-1
(1:500; catalog #33–9100, Thermo Fisher Scientific); mouse anti-E-cadherin (Ecad; 1:200; catalog #610181, BD Biosciences); and rabbit anti-connexin 31 (Cx31; 1:250; catalog #12880–1-AP, Proteintech Group). The
following secondary antibodies were used (1:500): Alexa Fluor 488 goat
anti-chicken (catalog #A11039, Thermo Fisher Scientific); Alexa Fluor 488
goat anti-mouse (catalog #A32723, Thermo Fisher Scientific); Alexa Fluor
488 goat anti-rabbit (catalog #A32731, Thermo Fisher Scientific); Alexa
Fluor 568 goat anti-mouse (catalog #A-11004, Thermo Fisher Scientific);
Alexa Fluor 568 goat anti-rabbit (catalog #A11036, Thermo Fisher
Scientific); Alexa Fluor 647 goat anti-mouse (catalog #A32728, Thermo
Fisher Scientific); and Alexa Fluor 647 goat anti-rabbit (catalog #A32733,
Thermo Fisher Scientific).
Confocal imaging and image analysis
To measure astrocyte morphology, fluorescent images were acquired
using a Zeiss LSM 880 laser scanning confocal microscope with 63 oilimmersion objective with frame size at 1024  1024 and bit depth at 12.
Serial images at z-axis were taken at an optical step of 1 mm, with overall
z-axis range encompassing the whole section. Images were imported to
Imaris Bitplane software, and only astrocytes with their soma between
the z-axis range were chosen for further analysis (Lanjakornsiripan et al.,
2018). We performed 3D surface rendering using the Imaris Surface
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Figure 1. Deletion of Med12 in mature astrocytes selectively reduces morphologic complexity. A–H, Coexpression of Med12 and Aldh1l1-GFP in AG12-Con and AG12-KO
mice. Filled arrowheads show coexpression of Aldh1l1-GFP and Med12; unfilled arrowheads show Aldh1l1-GFP cells that do not express Med12. I, Tamoxifen treatment paradigm. J–Q, High-magnification confocal images of Aldh1l1-GFP from AG12-Con or AG12-KO mice showing reduced complexity in the cortex and hippocampus. R,
Quantification of Med12/Aldh1l1-GFP coexpression in AG12-Con and AG12-KO mice. Data are derived from three mice per genotype, three slides per region, per mouse: at
least 500 cells per region, per mouse. One-way ANOVA. S–V, Scholl analysis of astrocyte complexity in the cortex, olfactory bulb, brainstem, and hippocampus. Data are
derived from three mice per genotype, three slides per region, per mouse, with at least 30 cells per region per genotype; two-way repeated-measures ANOVA. W,
Quantification of Aldh1l1-GFP/DAPI coexpression in AG12-Con and AG12-KO mice. Data are derived from three mice per genotype, three slides per region, per mouse: at least
500 cells per region, per mouse. One-way ANOVA. NS: not significant. *p , 0.05.
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module and color coded the reconstructed surface images based on the surface area of each
astrocyte. Morphologic analysis was performed
using the Imaris Filament module. Astrocyte
branches and processes were outlined by
Autopath with a starting point set at 10 mm
and seed point set at 0.5 mm, and statistical outputs including ‘‘filament number Sholl intersections’’ were extracted and plotted with Prism
software. Data were generated from three brain
sections per region per mouse, with three mice
per genotype. To analyze the number of astrocytes and Med12 knockout efficiency, fluorescent images were acquired using a Zeiss LSM
880 laser-scanning confocal microscope with a
20 objective. Cell numbers were quantified by
the QuPath software Cell Detection function
(Bankhead et al., 2017). To examine the cochlea, fluorescent images were acquired using a
Zeiss LSM 880 laser-scanning confocal microscope with a 20 objective.
Behavioral tests
Fear conditioning. Fear conditioning was
Figure 2. Deletion of Med12 results in hearing loss and no changes in synaptic plasticity in the hippocampus. A, B,
performed as previously described (Samaco et
Quantification of freezing in cued fear conditioning (A) and startle responses in acoustic startle (B). In A, four AG12-Con and
al., 2008). Mice were tested at 4 months of age
five AG12-KO mice were used; in B, three AG12-Con and four AG12-KO mice were used. Two-tailed unpaired t test. AG12in a chamber that contains a grid floor that can
Con denotes Med12fl/fl; Aldh1l1-GFP and Med12fl/y; Aldh1l1-GFP. AG12-KO denotes Med12fl/fl; Aldh1l1-CreER; Aldh1l1-GFP
deliver an electric shock (Actimetrics Chamber
and Med12fl/y; Aldh1l1-CreER; Aldh1l1-GFP. *p , 0.05; **p , 0.01. C, Schematic of LTP recording experimental setting. D,
System, Med Associates). On day 1 of the test,
LTP traces from AG12-Con and AG12-KO hippocampal slices. E, Quantification of LTP. All electrophysiological experiments are
mice were placed in the chamber and left undisderived from three mice from each genotype, ranging from 7 to 13 cells total for each experiment. NS, No significance.
turbed for 2 min followed by a 30 s white noise
*p , 0.05; **p , 0.001; Student’s two-tailed paired (L) t test. AG12-Con denotes Med12fl/fl; Aldh1l1-GFP and Med12fl/y;
sound pulse (“cue”). At the end of the cue, the
Aldh1l1-GFP.
AG12-KO denotes Med12fl/fl; Aldh1l1-CreER; Aldh1l1-GFP and Med12fl/y; Aldh1l1-CreER; Aldh1l1-GFP. Stim.,
mouse was shocked (2 s, 0.4 mA). Two minutes
Stimulus; Rec., recording; Ctrl, control.
later, a second pairing of sound cue followed by
shock was delivered. Thirty seconds after the
final shock, the animal was removed and placed
duration, 21 presentations/s) from 4 to 48 kHz were generated using
back to the home cage. The following day, the
System 3 Digital Signal Processing hardware and software (Tuckeranimals were again placed in the same chamber (“context test”) and
Davis Technologies). The intensity of the tone stimuli was calibrated
freezing behavior was recorded for 6 min. Freezing behavior was
using a type 4938 one-quarter inch pressure-field calibration microrecorded automatically by the instrument. One hour after the context
phone (Brüel & Kjær). EC1 ultrasonic, low-distortion electrostatic speaktest, the animals were placed into a chamber that had been cleaned with
ers were coupled to the ear canal to deliver stimuli within 3 mm of the
an unfamiliar agent (ethanol), and the wall color, the chamber shape,
tympanic membrane. Response signals were recorded with subcutaneous
and the odor (artificial vanilla) had been changed to remove the contexneedle electrodes inserted at the vertex of the scalp (channel 1), the posttual cues of the chamber. The animals were then monitored for 3 min.
auricular bulla region (reference), and the back leg (ground), and averAfter 3 min, the white noise cue was started and lasted 3 min. The
aged over 500 presentations of the tone bursts. Electrode-recorded
amount of freezing was recorded separately for the first 3 min and for
activity was filtered (high pass, 300 Hz; low pass, 3 kHz; notch, 60 Hz)
the last 3 min (cue test). The number of freezing intervals was converted
before averaging to minimize background noise. Auditory thresholds
to a percentage of freezing for both the context test and the cue test, and
were determined by decreasing the sound intensity of each stimulus to
the data were analyzed using a one-way ANOVA.
10 dB from 90 dB in 5 dB steps until the lowest sound intensity with reAcoustic startle response. Acoustic startle response and prepulse inhiproducible and recognizable waveforms was detected. Thresholds were
bition were performed as previously described (Samaco et al., 2008).
determined to within 5 dB for each frequency by two raters to ensure
Mice at 4 months of age were subjected to acoustic prepulse inhibition
reliability. SDs (dB SPL) were plotted as a function of stimulus frequency
test. The acoustic prepulse inhibition task consists of presenting the ani(in kilohertz) and analyzed for group differences by a two-way ANOVA,
mal with two closely paired sound pulses, as follows: a prepulse at
followed by a multiple-comparison test, to reveal overall trends.
10 dB, 14 dB (74 dB), 18 dB (78 dB), 112 dB (82 dB), and over background followed 100 ms later by a pulse of 120 dB. The amount of startle
Distortion product otoacoustic emission
that the pulse induces in the animal is recorded using a startle chamber
Distortion product otoacoustic emissions (DPOAEs; 2f1-f2) were measfor mice (SR-Lab, San Diego Instruments), which records activity for
ured from the left ears in sessions separate from ABR recording. Twelve
65 ms after the pulse. The maximum amplitude recorded over the 65 ms
A12-KO mice (3 females) and 9 A12-Con mice (1 female) were prepared
is recorded and compared using an ANOVA. No prepulse inhibition
as for ABR measures. Input–output curves were obtained for primary
result is presented because the Med12-deficient mice showed no acoustic
stimulus frequencies f1 and f2, where f1 = f2/1.2 at fixed level differences
startle response.
L1 and L2, where L2 = L1–10 dB. DPOAEs were measured for f2 = 12,
Auditory brainstem response recording. Auditory brainstem response
18, and 24 kHz, and L2 levels ranging from 0 to 80 dB SPL in 5 dB steps.
recording was performed as previously described (Manalo et al., 2020).
Stimuli were presented using two speakers (model EC1, Tucker-Davis
Mice were intraperitoneally injected with ketamine/xylazine (100:10 mg/
Technologies) configured in a closed acoustic system along with a
kg). The depth of anesthesia was verified by the absence of toe-pinch
Knowles probe microphone to record speaker and cochlear output.
reflex. Testing was performed in a soundproof Faraday cage booth while
Primary and DPOAE levels were recorded using EMAV software in conmice were placed on heating pad to maintain normal body temperature
junction with Tucker-Davis Techologies and custom hardware. DPOAE
throughout the procedure. Pure tone bursts (0.1 ms rise/fall, 2 ms
thresholds were defined as a 2f1-f2 response of at least 15 dB SPL. This
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software. We assessed the significance of data for
comparison by Student’s two-tailed unpaired/
paired t test or two-tailed unpaired t test. For multiple comparisons, we used the one-way ANOVA
with Tukey’s test and two-way ANOVA with
Sidak’s test. In general, we assumed that data were
normally distributed, but this was not formally
tested. Data are presented as the mean 6 SEM.
Levels of statistical significance are indicated as follows: *p , 0.05, **p , 0.01, ***p , 0.001.

Results
Deletion of Med12 selectively reduces
morphologic complexity of astrocytes
To decipher whether Med12 plays a role in
astrocyte function in the adult brain, we evaluated its expression in astrocytes by coimmunostaining with GFP and Med12 in 16-weekold Aldh1l1-GFP reporter mice. This analysis
revealed that ;70% of Aldh1l1-GFP astrocytes
express Med12 in the olfactory bulb (73.1 6
2.3%) and ;50% across other examined brain
regions (Fig. 1A–D,R; cortex, 52.0 6 2.3%;
hippocampus, 48.5 6 8.8%; brainstem, 57.9 6
5.2%); Med12 also exhibited expression in
NeuN-positive neurons in these same brain
regions.
Med12 plays an important role in numerous developing tissues, rendering the germline embryonic knockout lethal (Rocha et al.,
2010a,b) and requiring the generation of
temporal and lineage-specific knock-out
alleles to study its role in mature astrocytes. To specifically knock out Med12 in
astrocytes in the adult brain, we acquired
mice containing a floxed Med12 allele
Figure 3. Med12 deletion causes rapid peripheral hearing loss in adult mice. A, Tamoxifen treatment paradigm for
(Med12fl/fl) and intercrossed it with the
weekly ABR tests. B–E, ABR thresholds at different frequencies before (B), after 1 week (C), after 2 weeks (D), and after
Aldh1l1-CreER line and the Aldh1l1-GFP
3 weeks (E) of the tamoxifen treatment. Dashed lines mark the maximum pressure, 90 dB, used in the tests. In B, Nine
reporter, producing the Aldh1l1-CreER;
AG12-Con and 8 AG12-KO mice were recorded; in C, 6 AG12-Con and 7 AG12-KO mice were recorded; in D, 4 AG12-Con
and 6 AG12-KO mice were recorded; in E, 9 AG12-Con and 10 AG12-KO mice were recorded. F, G, ABR to stimuli of 60–
Aldh1l1-GFP; Med12fl/fl and Aldh1l190 dB SPL (8 kHz) in AG12-Con (F) and AG12-KO (G) mice. AG12-Con denotes Med12fl/fl; Aldh1l1-GFP and Med12fl/y;
CreER; Aldh1l1-GFP; Med12fl/y (AG12)
fl/fl
and Aldh1l1-GFP. AG12-KO denotes Med12 ; Aldh1l1-CreER; Aldh1l1-GFP and Med12fl/y; Aldh1l1-CreER; Aldh1l1-GFP.
mouse lines. TM was administered at postTwo-way repeated-measures ANOVA. *p , 0.05; **p , 0.01.
natal day 30 (P30), which allowed us to
bypass possible developmental roles for
level was chosen as it represented the lowest criterion response that was reliMed12. Mice were harvested 2 months afably above background noise levels and was generally within 10 dB of ABR
ter TM treatment (P80 to P90) and stained for Med12. We
thresholds.
observed the loss of Med12 in .50% of Aldh1l1-GFP-posiEndocochlear potential recording
tive astrocytes in the olfactory bulb, cortex, hippocampus,
EP recordings were obtained from the left ear of 10 A12-KO mice
and brainstem 2 months after treatment (Fig. 1A–H,R; in
(2 females) and 9 A12-Con mice (1 female). To record the EP, animals were
Aldh1l1-GFP astrocytes that express Med12 in AG12-Con:
anesthetized with 80 mg/kg ketamine, 15 mg/kg xylazine, i.p., and posiolfactory bulb, 73.1 6 2.3%; cortex, 52.0 6 5.1%; hippocamtioned ventral-side up in a custom head holder. Core temperature was
pus, 48.5 6 8.8%; brainstem, 57.9 6 5.2%; in AG12-KO: olmaintained at 37.5 6 1.0°C using a DC electric heating pad in conjunction
factory bulb, 28.0 6 5.6%; cortex, 31.7 6 4.5%; hippocampus,
with a rectal probe (FHC). After blunt dissection of the jaw musculature to
9.4 6 4.7%; brainstem, 28 6 12%). We were unable to achieve
reveal the left auditory bulla and opening of the posterior bulla with forceps,
higher KO efficiency because prolonging TM treatment led
a hole was made in the cochlear capsule directly over scala media of the
lower basal turn using a fine drill. Glass capillary pipettes (20–30 MV) filled
to severe gastrointestinal illness, which ultimately resulted in
with 0.15 M KCl were mounted on a hydraulic microdrive (Frederick Haer)
death.
and advanced until a stable positive potential was observed that did not
To determine whether the deletion of Med12 impacts astrochange with increased electrode depth. The signal from the recording eleccyte homeostasis, we assessed their morphology using confocal
trode was led to an intracellular amplifier (Model 1600, AM Systems).
imaging of the Aldh1l1-GFP reporter in AG12-Con and AG12KO brains. Three-dimensional reconstructions of these images
Quantification and statistical analysis
were subjected to Sholl analysis to evaluate the morphologic
Sample sizes and statistical tests can be found in accompanying figure
legends. Offline analysis was conducted using SPSS 20 and Excel
complexity of astrocytes. This analysis revealed that astrocytes
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from AG12-KO mice demonstrate
reduced complexity in the prefrontal
cortex and CA1 of the hippocampus,
whereas astrocytes from the olfactory
bulb and brainstem were unaffected
(Fig. 1J–Q,S–V). Quantification of the
gross numbers of Sox9-expressing
astrocytes did not reveal any differences between AG12-Con and AG12-KO
mice (Aldh1l1-GFP1/DAPI ratio in
AG12-Con: olfactory bulb, 15.5 6 2.8%;
cortex, 13.6 6 2.2%; hippocampus, 25.7 6
6.8%; brainstem, 10.3 6 2.3%; in AG12KO: olfactory bulb, 14.9 6 1.6%; cortex,
15.6 6 1.9%; hippocampus, 26.1 6 2.7%;
brainstem, 9.6 6 2.2%), indicating that loss
of Med12 does not lead to cell death (Fig.
1W). Together, these studies indicate that
Med12 is selectively required to maintain the morphologic complexity of
astrocytes in the hippocampus and
cortex, but is not required in the olfactory bulb or brainstem.
Elimination of Med12 leads to rapid
hearing loss
The foregoing observation that the loss
of Med12 results in decreased morphologic complexity of astrocytes in the hippocampus and prefrontal cortex, led us
to examine whether these cellular phenotypes lead to behavioral deficits associated with these brain regions. Since the
hippocampus demonstrated the most efficient knockout of Med12, we conducted
fear-conditioning assays, which are associated with hippocampal function. As
shown in Figure 2A, AG12-Con mice
showed significantly increased freezing
behaviors after the auditory cue (AG12Con mice: no cue, 25.3 6 1.5%; cued,
75.2 6 3.2%); however, AG12-KO mice
demonstrated no change in freezing
before and during the auditory cue (Fig.
2A; AG12-KO mice: no cue, 6.7 6 1.7%; Figure 4. Deletion of Med12 has latent effects on the structure of organ of Corti. A–X, Detection of the markers of supportcued, 17.1 6 5.4%). Further analysis ing cells, Sox2, and hair cells, Myo7a, by immunofluorescence on midmodiolar sections of cochleae of AG12-Con and AG12-KO
mice. Figures show the organ of Corti in the basal turn. A comparison of midmodiolar sections of cochleae of AG12-Con and
revealed that the AG12-KO mice did not AG12-KO mice 3 weeks post-TM (A–H), 5 weeks post-TM (I–P), and 18 weeks post-TM (Q–X). AG12-Con denotes Med12fl/fl;
respond to acoustic stimulation (Fig. 2B; Aldh1l1-GFP and Med12fl/y; Aldh1l1-GFP. AG12-KO denotes Med12fl/fl; Aldh1l1-CreER; Aldh1l1-GFP and Med12fl/y; Aldh1l1AG12-Con mice, 2495.2 6 492.1 a.u.; CreER; Aldh1l1-GFP. Scale bar, D, 20 mm.
AG12-KO mice, 58.0 6 11.9 a.u.), indicating that the apparent deficits in fear
TM-induced deletion (Fig. 3A), finding dramatic elevation
conditioning are likely the result of impaired hearing. Consistent
of auditory thresholds at 1 week post-TM treatment (at 4
with this interpretation, we did not observe any changes in
kHz: AG12-Con mice, 63.3 6 1.7 dB SPL; AG12-KO mice,
short-term potentiation (STP) or long-term potentiation (LTP)
77.9 6 4.9 dB SPL; at 16 kHz: AG12-Con mice, 49.2 6 2.4 dB
in the hippocampus of AG12-KO mice compared with AG12SPL; AG12-KO mice, 65.7 6 6.3 dB SPL), culminating in a
Con mice (Fig. 2C–E; LTP: AG12-Con mice, 120.69 6 14.43%;
complete loss of auditory response to all stimulation by 3
AG12-KO mice, 124.8 6 25.67%).
weeks post-TM treatment (Fig. 3C,D; 4–32 kHz; AG12-KO
The loss of hearing in the AG12-KO mice prompted us to
mice with no response). To identify the possible cause of
further examine auditory function by measuring ABRs. We
hearing loss, we further examined the recording of auditory
first established a baseline ABR for AG12-Con and AG12brainstem responses from each group at 3 weeks after TM
KO mice before TM-induced deletion of Med12, finding no
induction. ABR responses at 8 kHz in AG12-Con mice
differences in ABR thresholds between two groups (Fig. 3B;
revealed five clearly defined maxima, which represent major
4–32 kHz). Next, we evaluated ABR in weekly intervals postABR peaks I to V (Fig. 3F). In contrast, we did not observe
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not reveal any overt structural changes in
supporting cells (Sox21) or hair cell
(Myo7a1) populations (Fig. 4A–H; three
animals in each group were analyzed).
Moreover, analysis at 5 weeks post-TM
induction also did not show any changes
in the cellular integrity of the organ of
Corti (Fig. 4I–P; three animals in each
group were analyzed). However, analysis
at 18 weeks post-TM induction did reveal
an eventual loss of Myo7a-expressing hair
cells, coupled with disorganization of
Sox2-expressing support cells and a general breakdown in organ of Corti integrity
(Fig. 4Q–X; three animals in each group
were analyzed). Nevertheless, the latent
loss of hair cells at 18 weeks after Med12
deletion does not coincide with the
observed loss of ABR at 2–3 weeks postdeletion (Fig. 3), indicating that Med12-dependent loss of ABR is likely mediated
through other cellular mechanisms in the
adult cochlea.
Next, we examined additional structures in the cochlea, finding that
Aldh1l1-GFP is also colocalized to the
spiral ligament and basal cells of the
stria vascularis (Fig. 5A–D). Strikingly,
at 3 weeks post-TM induction the stria
vascularis of AG12-KO mice exhibited
drastic alterations in its integrity, highlighted by alterations in the structure of
ATP1A1-expressing intermediate cells
at the apical turn (Fig. 5, compare C,D,
G,H, yellow arrows). Analysis at 5 weeks
post-TM revealed that ATP1A1-expressing intermediate cells are completely lost
from middle to apical turns in AG12-KO
mice, which further disrupts the archiFigure 5. Med12 expression in basal cells is required to maintain the stria vascularis. A–P, Detection of the stria vascularis
tecture of these structures (Fig. 5I–P).
marker, ATP1A1, by immunofluorescence on midmodiolar sections of cochleae of AG12-Con and AG12-KO mice. Figures show
Given the essential role of the stria vasthe stria vascularis in the apical turn. Yellow arrowheads mark the regions of stria vascularis. A comparison of midmodiolar
cularis in maintaining the ionic composections of cochleae of AG12-Con and AG12-KO mice 3 weeks post-TM (A–H) and 5 weeks post-TM (I–P). Q–V,
sition of endolymph, these findings
Immunostaining of Med12 in stria vascularis of midmodiolar sections of cochleae of AG12-Con and AG12-KO mice at 2 weeks
suggest that progressive loss of the stria
post-TM. Figures show the stria vascularis in the middle turn. R–S and U–V are the regions from dashed squares in Q and T.
vascularis results in ionic imbalance of
Unfilled arrowheads mark the sides of intermediate cells; yellow arrowheads mark the sides of basal cells and the spiral ligathe endolymph, which compromises hair
ment. AG12-Con denotes Med12fl/fl; Aldh1l1-GFP and Med12fl/y; Aldh1l1-GFP. AG12-KO denotes Med12fl/fl; Aldh1l1-CreER;
cell function, leading to hearing loss in
Aldh1l1-GFP and Med12fl/y; Aldh1l1-CreER; Aldh1l1-GFP. W, Quantification of Med12 expression in Aldh1l1-GFP basal cells;
AG12-KO mice.
*p , 0.05. Scale bars: D, 50 mm; Q, 20 mm.
To decipher which cell populations
in
the
cochlea are dependent on Med12
any of the major ABR peaks in AG12-KO mice 3 weeks after
expression,
we
used
immunostaining
to determine its pattern
TM treatment (Fig. 3G). ABR wave I corresponds to comof expression. Staining for Med12 was observed in the stria
pound auditory nerve conduction; therefore, its loss in the
vascularis in AG12-con mice 3 weeks post-TM induction
AG12-KO mice indicates that Med12 deletion results in dys(Fig. 5Q,R). Nuclear localization of Med12 was observed in
function of the inner ear, which inhibits initiation of the aubasal
cells and fibrocytes in the spiral ligament (Fig. 5R, yelditory response.
low arrowheads). Analysis of Med12 expression in AG12-KO
mice revealed that the nuclear localized expression in basal
Med12 is required to maintain the structural integrity of the
cells was significantly decreased (Fig. 5, compare R, T). The
percentage of Med12-positive basal cells reduced from
stria vascularis
Having established that the loss of hearing in AG12-KO mice is
91.2 6 5.9% (AG12-con mice, n = 3) to 25.1 6 1.2% (AG12likely because of defects in the inner ear, we next examined the
KO mice, n = 3; Fig. 5W). These observations suggest that
cellular integrity of the cochlea. Starting with the organ of Corti,
Med12 deletion is occurring in the basal cells of the stria vascularis in the AG12-KO mouse line.
analysis of AG12-KO mice at 3 weeks post-TM induction did
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Med12 deletion disrupts basal cell
organization
To track which populations in the
cochlea undergo TM-induced Crerecombination in the Aldh1l1-CreER
line, we replaced the Aldh1l1-GFP reporter with a Cre-inducible reporter,
generating the Aldh1l1-CreER; RosaCAG-LSL-tdTomato; Med12fl/f mouse
line (i.e., AT12 line). We treated AT12Con mice with TM and harvested the
cochlea 2 weeks after induction, finding
that the tdTomato reporter labeled the
Glut1-expressing basal cells of the stria
vascularis and some fibrocytes in the
spiral ligament (Fig. 6A–D, yellow
arrowheads), but not spiral ganglion
cells (data not shown). Consistent with
a requirement for Med12 expression in
basal cells, examination of AT12-KO
mice 2 weeks after TM induction
revealed a loss of basal cell organization, where Glut1- and tdTomatoexpressing basal cells appear diffuse
and lose cell–cell contact (Fig. 6E–H,
unfilled arrowheads; three animals in
each group were analyzed, phenotype
was observed in all AT12-KO mice).
Together, these findings indicate that
Med12 is required to maintain the organization and integrity of basal cells in
the stria vacularis.
Adhesion between cell types within
the stria vascularis is required to generate
and preserve ion gradients in the endolymph, which are essential for maintaining endocochlear potential and auditory
function (Ciuman, 2009; Wan et al.,
2013). Our observed cellular phenotypes
in basal cells of the AT12-KO line suggest
that cell adhesion within the stria vascularis is disrupted. To test this, we evaluated the expression of key junction
proteins associated with hearing loss in
this region, ZO1, Ecad, and Cx31. In
AT12-Con animals, ZO1 is concentrated
next to the cell membrane of basal cells;
however, ZO1 expression level was dramatically decreased in AT12-KO mice
(Fig. 6I–L, white arrowheads; the inten- Figure 6. Med12 is required to maintain expression of cell adhesion proteins. A–H, Detection of Glut1, an endothelial and
sity ratio was reduced to 0.696 6 0.026 basal cell marker, by immunofluorescence on midmodiolar sections of cochleae of AT12-Con and AT12-KO mice at 2 weeks
compared with AT12-Con; n = 3 in each post-TM. Figures show the stria vascularis in the middle turn. Yellow arrowheads denote Glut1-positive basal cells, labeled by
group). Cx31 protein was highly concen- AT12-Con tdTomato reporter (B, C); unfilled arrowheads denote disorganized Glut-1/tdTomato basal cells in AT12-KO (F, G).
trated between basal cells and fibrocytes I–T, Detection of ZO1, E-cadherin, and Connexin-31 proteins by immunofluorescence on midmodiolar sections of cochleae of
in spiral ligament in AT12-Con mice and AG12-Con and AG12-KO mice at 2 weeks post-TM. I, M, Q, Filled arrowheads denote AG12-Con expression of makers. K, O, S,
demonstrated disorganized localization Unfilled arrows denote altered expression of markers in AG12-KO. U, Quantification of immunostaining from I to T; *p , 0.05.
in AT12-KO mice (Fig. 6M–P, white Scale bars: D, L, 50 mm.
arrowheads; Fig. 6U, the intensity ratio
with AT12-Con mice (Fig. 6Q–T,U; intensity ratio, 1.036 6 0.047;
was reduced to 0.689 6 0.103 compared
compared with AT12-Con; n = 3 in each group). These findings
with AT12-Con; n = 3 in each group). Ecad expression was
suggested that Med12 is necessary to maintain the expression of
mainly observed in both intermediate cells and basal cells (Fig. 6Q,
these critical junction and cell adhesion proteins in the stria vasculaR). Although the distribution of Ecad was altered in AT12-KO mice
(Fig. 6S,T), the intensity was not significantly different compared
ris and spiral ligament.
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DPOAE values did not differ significantly
between AG12-Con and AG12-KO mice,
although control mice gave slightly higher
values (30.5 vs 36.2 dB SPL; Fig. 7C).
Finally, a stria-specific defect is also predicted to yield DPOAE thresholds that are
lower relative to ABR thresholds, meaning
that ABR–DPOAE threshold differences
should be higher when the stria is compromised. Indeed, this metric both averaged
(0.83 vs 5.04 dB) and skewed higher in
the AG12-KO mice (Fig. 7D), supporting
the existence of isolated strial dysfunction
in the majority of AG12-KO mice. In sum,
ABR, EP, and DPOAE data supported a
central tendency toward isolated strial dysfunction in the AG12-KO mice as early as
10–14 d after TM-induced deletion.

Discussion
Mutations in MED12 are linked to a broad
spectrum of genetic disorders with Xlinked intellectual disability (Schwartz et
al., 2007; Lesca et al., 2013; Vulto-van
Silfhout et al., 2013; Donnio et al., 2017;
Rubinato et al., 2020); however, embryonic
lethality
in Med12-null and heterozygous
Figure 7. Loss of Med12 results in stria vascularis-specific defects. A, ABR thresholds were significantly higher in KOs vermice have hindered the study of these
sus controls (two-way ANOVA, F = 46.188, df = 6, p , 0.001) with no significant interactions. B, EPs were significantly lower
in KOs (t test for unequal variance, df = 11, t = 7.23, p , 0.001). C, 2f1-f2 maximum values were not significantly differMed12-associated phenotypes (Rocha et
ent by group (t test for unequal variance, df = 60, t = 1.84, p , 0.07). D, Difference in ABR versus DPOAE threshold
al., 2010a,b). Here, we applied temporal
(ABR-DPOAE for 15 dB SPL criterion) was significantly higher in KOs (t test for unequal variance, df = 59, t = 2.32,
and tissue-specific approaches to study
p , 0.02). DPOAE metrics were derived from input–output curves for f2 = 12, 18, and 24 kHz (see horizontal bar in A).
Med12 function in adult astrocytes in the
Since these curves did not differ by f2 (data not shown), data from all three frequencies were included in C and D.
CNS. Critically, the lethality rate dramatically increased with prolonged tamoxifen
treatment, which likely prevented us from
Reduced endocochlear potential in Med12 mutant mice
achieving a high KO efficiency in astroThe foregoing studies indicate that the loss of Med12 disrupts
1R). This technical limitation may have
cytes
in
the
CNS
(Fig.
the organization of the basal cells as early as 2 weeks after TMmasked some CNS-related phenotypes associated with Med12
induced deletion, suggesting that the cascade of cellular events
function. Surprisingly, we found that Aldh1l1-CreER-mediated
that lead to hearing loss originates in the stria vascularis.
Med12 deletion in the adult led to rapid hearing loss. Although
Therefore, we next measured the EP in AG12-Con and AG12hearing loss has been reported in cases of Med12-related disorKO mice 10–14 d after TM-induced deletion. Consistent with
ders (Rubinato et al., 2020), the underlying mechanisms
our prior results (Fig. 3), AG12-KO mice showed ABR threshremained undefined. We found that Med12 is necessary for
olds that were 15–25 dB higher than those in AA2-Con mice.
maintaining the integrity of the stria vascularis in the adult, likely
These differences were significant overall (p , 0.001), with
by regulating the expression of ZO-1, Ecad, and Cx31. These
no interactions by frequency (Fig. 7A). The overall relative
changes in gene expression alter cell adhesion between basal cells
“flat” threshold shift in the AG12-KO mice compared with
and the spiral ligament, which would likely impede the generaAG12-Con supports a non-frequency-specific influence,
tion of normal endolymph and culminates in loss of hair cell
consistent with isolated strial dysfunction (Schuknecht and
mechanotransduction.
Gacek,1993). EP recordings from the same cochleas (Fig. 7B)
Our studies revealed that basal cells and the spiral ligament of
revealed no overlap of EP values by group (p , 0.001), with
the adult cochlea are transcriptionally dependent on Med12 to
AG12-Con mice showing typical values for C57BL/6 mice
maintain their overall structural integrity. We recently identified
(.100 mV; Ohlemiller, 2009) and AG12-KO mice averaging
similar transcriptional dependencies in the adult brain, where
;30 mV lower (76.8 vs 106.7 mV).
the transcription factor NFIA is required to maintain the morTo confirm that these mice, at this time point, have stria-spephologic complexity of hippocampal astrocytes (Huang et al.,
cific defects, we next performed distortion DPOAE tests on these
2020). Together, these studies highlight adult- and region-spesame mice (Ueberfuhr, et al., 2016). In the presence of an isolated
cific roles for developmental transcription factors in maintaining
strial defect, maximum DPOAE values should be similar for norkey aspects of cell structure in mature populations. Med12 funcmal and stria-impaired mice, and DPOAE thresholds should be
tions, in part, to maintain the expression of key proteins that
spared relative to ABR thresholds at the same frequencies (Mills,
maintain tight junctions (TJs) and gap junctions (GJs), which are
2003). Since the DPOAE input/output results did not vary with
critical for normal cochlear function (Wangemann, 2006; Wan
f2 frequency, data from f2 = 12, 18, 24 kHz were all included
from each animal. This analysis revealed that the maximum
et al., 2013). Prior studies indicate that genetic deletion of either
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Ecad (Trowe et al., 2011) or Cx31 (López-Bigas et al., 2001) during development results in hearing loss, suggesting that their regulation by Med12 contributes to the observed hearing loss in the
adult. While our studies suggest that the downregulation of these
structural proteins is responsible for the effects of Med12 loss in
the cochlea, it is possible that Med12 regulates the expression of
other genes that are also important for these effects. Further
studies on Med12 target gene networks in basal cells will be critical for deciphering these regulatory networks and associated
mechanisms.
Our findings demonstrate that the loss of Med12 in basal
cells and that the spiral ligament leads to defects of the stria
vascularis. Progressive degeneration of the stria vascularis
underlies a form of age-related hearing loss known as strial
or metabolic presbycusis (Schuknecht and Gacek, 1993).
However, we cannot exclude the possibility that the loss of
Med12 in other tissues contributes to hearing loss in
humans. Med12 expression is also observed in supporting
cells in cochlea and in major cell types in nervous system,
raising the possibility that it has related functions in these
systems. Nevertheless, our study describes the first animal
model that recapitulates hearing loss identified in Med12related disorders and provides a new system in which to
examine the underlying cellular and molecular mechanisms.
Moreover, the TJ and GJ proteins that are downregulated in
the Med12-deficient cochlea also play important roles in
other systems; for example, ZO1 is highly expressed in circumventricular organs of the CNS and is required for the integrity of blood–brain barrier (Petrov et al., 1994), and a
Cx31 mutation leads to peripheral neuropathy in addition to
sensorineural hearing impairment in patients (López-Bigas
et al., 2001). Therefore, our studies lay the foundation for
further examination of Med12 function in other systems
linked to Med12-disorders.
To ascertain whether the initial defects in the AG12-KO cochlea are because of strial dysfunction, we measured a series of
physiological parameters associated with cochlear function at
time points where basal cell organization is altered and the organ
of Corti is intact. The most essential evidence for strial pathology
in the AG12-KO mouse derives from direct EP recordings, where
AG12-KO and AG12-Con mice showed no overlap of EP values,
with the AG12-KO mice averaging an ;30 mV decrease in EP.
Thus, all of the AG12-KO mice exhibited the single functional
requirement for strial pathology, although this does not directly
address whether other defects are present at these relatively early
time points (i.e., 10–14 d post-TM). Other evidence for strialspecific defects at these early time points are based on no changes
in the DPOAE input/output data between the AG12-KO and
AG12-Con mice, coupled with a relative sparing of DPOAE
thresholds versus ABR (DPOAE–ABR) thresholds at the
same frequency (Mills, 2003), which yielded higher positive
values (ABR threshold higher) in the AG12-KO line. In sum,
four functional metrics supported an initial, delimited, strial
pathology in AA12-KO mice. EP reduction was the requisite
criterion, but since EP recording is a terminal procedure, it
cannot be used clinically. While we did not first conceive of
the threshold and DPOAE-based metrics, we used to evaluate
strial pathology in our AG12-KO mice, we believe we are the
first to apply all three criteria. The principal limitation to
such an approach at present is simply the lack of suitable
models. Thus, the Med12 KO model may represent a useful
system for additional studies aimed at detecting and characterizing isolated chronic EP reduction.
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